Perfect Peace Baptist Church

Obama bureaucrat brags about blocking HCQ drug

Unprecedented: Obama bureaucrat brags about blocking HCQ drug

How could a cheap, effective drug, FDA-approved and in use worldwide since 1955, suddenly be restricted for outpatient use by American physicians? On March 28, 2020, as physicians worldwide were seeing striking success using hydroxychloroquine to treat COVID-19, the FDA erected bureaucratic barriers.

Rick Bright, Ph.D., is an FDA bureaucrat, vaccine researcher and was appointed by President Obama on Nov. 15, 2016, to head BARDA (Biomedical Advance Research and Development Authority, a sub-agency of the FDA). In an unprecedented move, Bright expanded his power and claimed credit for being the person imposing his will on all of us.

In an appalling admission, Bright said: “Specifically, and contrary to misguided directives, I limited the broad use of chloroquine and hydroxychloroquine, promoted by the administration as a panacea, but which clearly lack scientific merit.” Meanwhile, he promoted both remdesivir, a never-approved experimental antiviral in development by Gilead Sciences, and a vaccine for COVID-19. Early effective use of the older, safe and available hydroxychloroquine, whose patents had expired decades ago, would decrease demand for these new products.

Rick Bright’s dictatorial decree limits the use of chloroquine (CQ) and hydroxychloroquine (HCQ) from the National Strategic Stockpile

https://www.wnd.com/2020/05/unprecedented-obama-bureaucrat-brags-blocking-hcq-drug/?utm_source=Email&utm_medium=wnd-brief&utm_campaign=dailypm&utm_content=brief

Leave a Comment

Your email address will not be published. Required fields are marked *

%d bloggers like this: